EU UCITS and AIF marketing communications must be fair, clear and not misleading and must not contradict or diminish the prospectus or KID. EU fund ads, fact sheets, web pages and social posts that describe a UCITS or AIF. This guide summarizes the supplied rule information for marketing review. Use the linked official source to confirm the current text, applicability
Ads for public offers or admissions of securities in the EU must be recognisable as ads, consistent with the prospectus, and state that a prospectus is or will be published and where to get it, that approval is not an endorsement, and that investors should read it before investing.
EU financial and crypto firms must not claim AMLA supervision or endorsement they do not have, or present AML compliance as an absolute guarantee, since this misleads consumers under the UCPD.
Australian businesses must not make false or misleading claims about a service's standard or quality, about performance, benefits, sponsorship or approval, or about the nature or suitability of goods and services.
Australian businesses must not make false or misleading claims that goods are of a particular quality, grade, composition, style, model or history, that they are new, about their price, or about their place of origin.
Corporations Act s 1041H and ASIC Act s 12DA prohibit misleading product labels and feature claims, including absolute or unexplained sustainability claims, which ASIC enforced in its 2024-2025 greenwashing penalty cases.
From Nov 12, 2026, federal law excludes synthesized cannabinoids (such as delta-8 made from CBD) and final hemp products over 0.4 mg total THC per container from the definition of hemp, and many states ban intoxicating hemp products; ads may not offer them as lawful hemp.
Request a free compliance scan of your homepage and book a time with Warrant.